Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- Check3 days agoChange DetectedTel Litwinsky, Israel, 52621 has been added to the Contacts and Locations section, while Qiryat Krinitzi, Israel, 52621 has been removed. This reflects a change in the participating sites in Israel.SummaryDifference0.1%

- Check10 days agoChange DetectedIsrael study locations were updated: a new site in Qiryat Krinitzi (52621) was added, and Tel Litwinsky (52621) was removed.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded 2023 ( U.S. NIH Grant/Contract ) to the study's Other Study ID Numbers and updated the revision to v3.6.6.SummaryDifference0.1%

- Check25 days agoChange DetectedNo textual changes were defined in the data. The page content remains as shown by the input.SummaryDifference0.0%

- Check32 days agoChange DetectedPlain Language Summary has been removed from the page. This removes a layperson-friendly overview of the study's purpose and design, making it harder for non-experts to quickly understand the trial.SummaryDifference0.1%

- Check39 days agoChange DetectedA new document revision v3.6.5 has been added, replacing the previous v3.6.4. This indicates an update to the study-related document version in the system, with no immediate changes to participant-facing information.SummaryDifference0.1%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.